JEUVEAU

Meet Jeuveau (prabotulinumtoxinA-xvfs)—aka the #NEWTOX! Jeuveau is a modern-made neurotoxin approved by the FDA to temporarily improve the appearance of frown lines.1 Jeuveau is the first and only product of its kind dedicated exclusively to aesthetics! As the fourth neurotoxin to hit the market (and the only new option in almost a decade), Jeuveau is made using a state-of-the-art manufacturing process called Hi-Pure technology.2 Jeuveau is the first product from Evolus, and part of its mission to bring a fresh experience and perspective to the aesthetics industry. It’s about time!

​

Questions?

What exactly is Jeuveau?

You know those pesky little wrinkles between your eyebrows that won’t go away? Well, they’re called glabellar lines, or “frown lines.”1 Jeuveau is an injectable treatment that works to temporarily improve the appearance of moderate to severe frown lines in adults How does Jeuveau work?

Jeuveau prevents your nerves from telling your facial muscles to flex.1 The result? In clinical trials, Jeuveau was shown to temporarily improve the appearance of moderate to severe frown lines.1 In 2 long-term safety studies, patients received an average of 3 treatments over the course of 1 year.

​

What are the results with Jeuveau?

In our 2 major clinical trials, when we checked at the 30-day mark, 67.5% of patients in 1 study and 70.4% of subjects in a second study were responders defined as a 2-point composite improvement agreed upon by physician and patient.

​

What’s it like before and after treatment?

f it’s your first time getting a treatment, you may be a little nervous. And that’s okay! Localized pain, infection, inflammation, tenderness, swelling, erythema, and/or bleeding/bruising may be associated with the injection. For specific instructions on what to do before and after your injection, please follow the instructions as given to you by your doctor or healthcare provider.

​

What are the side effects?

The most commonly reported side effects in clinical trials include headache, eyelid drooping, upper respiratory tract infection and increased white blood cell count.1 No serious drug-related adverse events were observed in the studies.